期刊名称：FOOD AND DRUG LAW JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
For over 50 years, this award-winning journal has offered readers scholarly, in-depth, analytical articles, providing insight into the actions of FDA, FTC, and USDA, how the courts interpret these actions, and the reaction of industry. Articles published in the Food and Drug Law Journal are heavily cited and reviewed by your peers. The Food and Drug Law Journal is published four times per year.
The Food and Drug Law Journal:
- Clarifies the complex regulation and legislation affecting the food,
drug, cosmetic, medical device, and healthcare technology industries.
- Explores the possible future implications of proposed regulations and policy trends.
- Analyzes critical court decisions in food and drug law, including intellectual property, antitrust, constitutional
and criminal law issues related to the health law field.
- Looks beyond our borders to assess how food- and drug-related
issues are regulated in other countries.
- Provides a neutral forum for intelligent discussion and debate among authors from private industry, government agencies, and academic institutions.
Achievements:
|
|
Instructions to Authors
Update is a bimonthly magazine that welcomes the contribution of articles on food and drug law, regulation, and education, and related areas.
Each issue of Update has a theme for its feature articles. See the Editorial Calendar for issue themes. The submission of nonfeature articles and Letters to the Editor for each issue also is encouraged. Update does not guarantee publication of submitted material.
Authors do not receive any type of remuneration from FDLI.
Types of Articles
Feature articles directly relate to the issue's theme. They include viewpoints on industry-specific trends, regulatory concerns, the latest developments in the law, and current events in the food and drug field throughout the United States and the world (1,500-2,500 words).
Nonfeature articles address a wide range of topics and generally are not related to an issue's theme (1,000-2,000 words).
Letters to the Editor address a single topic raised in a previous issue of Update (up to 500 words).
Style
Articles will be edited for length, style, content, grammar, and punctuation. A style guide for Update authors to follow is available. Authors are provided an opportunity to review the edited version of their article before it is published. If an author does not respond with changes to the edited version before the deadline for comments, the version faxed will be published.
Affiliation Statements & Photos
A single attribution line indicating current employment and location is required. Authors who are or have been involved as a principal or in a representative capacity with the subject matter of the article must so designate this in an additional attribution line. Full disclosure is necessary to provide reviewers and readers with useful information to assess the publication.
Authors may submit headshot photos along with their articles. These may be emailed along with the article or original photos may be provided, which will be scanned and returned.
Delivery
The preferred method for receiving articles is by email attachment as Word documents sent to the Editor-in-Chief, M. Cathryn Butler, at cat@fdli.org. Articles also may be submitted on an IBM-compatible computer disk, preferably in Microsoft Word, along with a hard copy of the article to:
M. Cathryn Butler, Editor-in-Chief
Update
Food and Drug Law Institute
1000 Vermont Ave., NW, Ste. 200
Washington, DC 20005-4903
phone: 202-371-1420 x 230
fax: 202-371-0649
email: cat@fdli.org
Authors may include art, illustrations, charts, and tables with their articles. Authors are responsible for obtaining reprint permission for any copyrighted material. These materials can be submitted on disk or as an email attachment.
Copyright
All authors, except government employees, must sign a copyright release form transferring copyright ownership to FDLI before the article will be published.
Reprints
Authors will receive two complimentary copies of the issue in which their article appears. After the issue is mailed, authors may receive a PDF version of their article, suitable for reprinting or posting on their organization's website.
Editorial Board
*Feature topics are subject to change. Articles (both feature and non-feature) for each issue are scheduled approximately one to two months in advance of the deadline for submission. In order to insure that your article is accepted and scheduled for publication in a specific issue of Update magazine, please contact Cathryn Butler, Editor-in-Chief, (202-371-1420 or cat@fdli.org) at least one to two months in advance of the deadline for the issue in which you seek publication. Articles that are received after the current issue is filled may be considered for publication in a future issue.
Articles also may be submitted on an IBM-compatible computer disk, preferably in Microsoft Word, along with a hard copy of the article to:
M. Cathryn Butler, Editor-in-Chief
Update
Food and Drug Law Institute
1000 Vermont Ave., NW, Ste. 200
Washington, DC 20005-4903
phone: 202-371-1420 x 230
fax: 202-371-0649
email: cat@fdli.org
|
刊名字顺( Alphabetical List of Journals):
返回页首 